CompletedPhase 1NCT00004736
Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis
Studying Tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Diane Havlir
- Intervention
- Nelfinavir mesylate(drug)
- Enrollment
- 44 enrolled
- Eligibility
- 18 years · All sexes
Study locations (10)
- Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States
- Univ of California / San Diego Treatment Ctr, San Diego, California, United States
- Cook County Hosp, Chicago, Illinois, United States
- Beth Israel Med Ctr, New York, New York, United States
- Bellevue Hosp / New York Univ Med Ctr, New York, New York, United States
- Columbia Presbyterian Med Ctr, New York, New York, United States
- Univ of Pennsylvania at Philadelphia, Philadelphia, Pennsylvania, United States
- Brown Univ / Miriam Hosp, Providence, Rhode Island, United States
- Miriam Hosp / Brown Univ, Providence, Rhode Island, United States
- Vanderbilt Univ Med Ctr, Nashville, Tennessee, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00004736 on ClinicalTrials.govOther trials for Tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07164742Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)Johns Hopkins University
- RECRUITINGNCT0707721318F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsChildren's Hospital Medical Center, Cincinnati
- ENROLLING BY INVITATIONNANCT06984887Evaluation of New TB Diagnostic Tests (NATs) in PakistanMercy Corps Pakistan
- RECRUITINGNCT07018076Candidate Clinical Correlate of Prognostic Outcome for TB StudyUniversity of California, San Francisco
- RECRUITINGNANCT07271225Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and VomitingIndonesia University
- RECRUITINGNCT06585358DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary TuberculosisKarolinska Institutet
- RECRUITINGPHASE3NCT06497465Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB TreatmentJohns Hopkins University
- RECRUITINGNCT07178860Respiratory Health and Wellbeing Post Pulmonary TuberculosisLiverpool School of Tropical Medicine